201 related articles for article (PubMed ID: 31371924)
1. Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.
Lin S; Li HY; Zhou T; Lin W
Drug Des Devel Ther; 2019; 13():2305-2330. PubMed ID: 31371924
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
Lin W; Li HY; Lin S; Zhou T
Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
Qiu TT; Zhang C; Zhao HW; Zhou JW
Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
Medicine (Baltimore); 2021 Jul; 100(28):e26628. PubMed ID: 34260552
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of three regimens (cyclosporine, tacrolimus, and cyclophosphamide) combined with steroids for the treatment of idiopathic membranous nephropathy.
Ruo-Ji C; Fang X; Zhen-Shuang D; Yu-Lin Z; Zi-Li Z; Wei-Yuan L
Nefrologia (Engl Ed); 2022; 42(6):671-679. PubMed ID: 36402685
[TBL] [Abstract][Full Text] [Related]
8. [The clinical efficacy and safety of modified Ponticelli regimen for treatment of idiopathic membranous nephropathy].
Xia W; Pei H; Li S; Fu S; Tian L
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):181-5. PubMed ID: 26926368
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials.
Huang H; Liang Z; Zheng X; Qing Q; Du X; Tang Z; Wei M; Wang C; Zhong Q; Lin X
Ren Fail; 2021 Dec; 43(1):840-850. PubMed ID: 34016023
[TBL] [Abstract][Full Text] [Related]
11. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: A network meta-analysis and cost-effectiveness analysis.
Dai P; Xie W; Yu X; Sun J; Wang S; Kawuki J
Int Immunopharmacol; 2021 May; 94():107376. PubMed ID: 33582591
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Tacrolimus versus Cyclosporine A for Idiopathic Membranous Nephropathy:A Network Meta-analysis.
Xu P; He YD; Yu ZM; Luo K; Xie HY; Zou PM; Gu X; Wang SR; Cai JF; Xu Q; Li H; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):41-51. PubMed ID: 29532780
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
[TBL] [Abstract][Full Text] [Related]
15. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults.
Li ZQ; Hu ML; Zhang C; Wang YM
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):623-628. PubMed ID: 26489612
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.
Chen M; Zhang X; Xiong Y; Xu G
Int Urol Nephrol; 2023 Mar; 55(3):641-651. PubMed ID: 36161550
[TBL] [Abstract][Full Text] [Related]
18. A comparison of cyclophosphamide versus tacrolimus in terms of treatment effect for idiopathic membranous nephropathy: A meta-analysis.
Li YC; Huang J; Li X; Zhao SM
Nefrologia (Engl Ed); 2019; 39(3):269-276. PubMed ID: 30755327
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis.
Li HY; Zhang X; Zhou T; Zhong Z; Zhong H
BMC Nephrol; 2019 Oct; 20(1):384. PubMed ID: 31646979
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A treatment for idiopathic membranous nephropathy.
Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
